Posted: 2:49 pm Thu, June 6, 2013
By Daily Record Staff
University of Maryland Ventures, a joint research commercialization effort of the University of Maryland, Baltimore and the University of Maryland, College Park, and Baltimore-based SilcsBio LLC, a supplier of computer-directed drug discovery software and services, announced that SilcsBio has obtained exclusive rights to a technology licensed from UMB.
Already a paid subscriber but not registered for online access yet? For instructions on how to get premium web access, click here.